Literature DB >> 12110607

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Martina Hayer-Zillgen1, Michael Brüss, Heinz Bönisch.   

Abstract

1. Organic cation transporters (OCTs) are involved in the elimination of monoamines and cationic xenobiotics. To examine whether some cell lines express several different OCTs, we investigated seven human cell lines for the mRNA expression pattern of the human (h) transporters hOCT1, hOCT2 and hOCT3. hOCT1 mRNA was found in all cell lines, six additionally expressed hOCT3 and only two cell lines contained all three hOCTs. 2. Among the three OCTs only for the OCT3 (also designated as 'uptake(2)' or 'extraneuronal monoamine transporter') 'selective' inhibitors are described in the literature. The affinities of the OCT3 inhibitors for the other two OCTs are largely unknown. Therefore, we compared the potencies of eight compounds as inhibitors of hOCT-mediated uptake of the organic cation [(3)H]-1-methyl-4-phenylpyridinium ([(3)H]-MPP(+)) in human embryonic kidney 293 (HEK293) cells stably expressing hOCT1, hOCT2 or hOCT3. Decynium-22 inhibited hOCT3 with 10 fold higher potency than hOCT1 and hOCT2. Corticosterone was about 100 fold more potent as inhibitor of hOCT3 than of hOCT1 or hOCT2, and O-methylisoprenaline (OMI) inhibited almost exclusively hOCT3. Progesterone and beta-Oestradiol preferentially inhibited hOCT3 and hOCT1, whereas prazosin was a potent inhibitor of hOCT1 and hOCT3. Phenoxybenzamine (PbA) inhibited with about equal apparent potency all three hOCTs, whereas the PbA derivative SKF550 ((9-fluorenyl)-N-methyl-beta-chloroethylamine) preferentially inhibited hOCT3 and hOCT2. 3. PbA reversibly inhibited hOCT1 and irreversibly hOCT2 and hOCT3; SKF550 also irreversibly inhibited hOCT3 but hOCT2 in a reversible manner. 4. These compounds enable a functional discrimination of the three hOCTs: hOCT1 is selectively inhibited by prazosin, reversibly inhibited by PbA and it is not sensitive to inhibition by SKF550 and OMI; hOCT2 is reversibly inhibited by SKF550, irreversibly by PbA and not by prazosin, beta-oestradiol and OMI, whereas hOCT3 is selectively inhibited by corticosterone, OMI and decynium22. British Journal of Pharmacology (2002) 136, 829-836

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110607      PMCID: PMC1573414          DOI: 10.1038/sj.bjp.0704785

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Effects of specific alpha-adrenoceptive agents on extraneuronal uptake (uptake2) of isoproterenol in perfused rat heart.

Authors:  Y Akimoto; K Sono; K Kurahashi; M Fujiwara
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

2.  Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines.

Authors:  P J Salt
Journal:  Eur J Pharmacol       Date:  1972-12       Impact factor: 4.432

Review 3.  Extraneuronal transport of catecholamines.

Authors:  H Bönisch
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

4.  Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells.

Authors:  D Gründemann; J Babin-Ebell; F Martel; N Ording; A Schmidt; E Schömig
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

5.  Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).

Authors:  M Hayer; H Bönisch; M Brüss
Journal:  Ann Hum Genet       Date:  1999-11       Impact factor: 1.670

6.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

Review 7.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines.

Authors:  G Eisenhofer
Journal:  Pharmacol Ther       Date:  2001-07       Impact factor: 12.310

8.  The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.

Authors:  L Zhang; W Gorset; M J Dresser; K M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

9.  Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine.

Authors:  L L Iversen; P J Salt; H A Wilson
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

10.  The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters.

Authors:  N Schweifer; D P Barlow
Journal:  Mamm Genome       Date:  1996-10       Impact factor: 2.957

View more
  85 in total

1.  Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.

Authors:  A Heinen; M Brüss; H Bönisch; M Göthert; G J Molderings
Journal:  Int J Colorectal Dis       Date:  2003-02-20       Impact factor: 2.571

2.  Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.

Authors:  O Sader-Mazbar; Y Loboda; M J Rabey; J P M Finberg
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 3.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

4.  Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives.

Authors:  Tomasz Grzela; Agata Bialoszewska; Robert Brawura-Biskupski-Samaha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04       Impact factor: 9.236

5.  Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.

Authors:  Jaclyn N Harper; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

6.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

7.  Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Authors:  Sandro Huenchuguala; Patricia Muñoz; Patricio Zavala; Mónica Villa; Carlos Cuevas; Ulises Ahumada; Rebecca Graumann; Beston F Nore; Eduardo Couve; Bengt Mannervik; Irmgard Paris; Juan Segura-Aguilar
Journal:  Autophagy       Date:  2014-01-14       Impact factor: 16.016

8.  Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.

Authors:  Britta Haenisch; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

9.  Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.

Authors:  Haichuan Duan; Tao Hu; Robert S Foti; Yongmei Pan; Peter W Swaan; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

10.  Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-10-17       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.